This September, the Dubai World Trade Centre will host ArabLab 2025, a key global gathering for laboratory innovation. BCL will be at Stall H2-C70, presenting solutions shaped by the region’s rapid growth in biotechnology.
The Middle East laboratory equipment market, valued at USD 1.38 billion in 2025, is projected to reach USD 2.55 billion by 2033, reflecting expanding healthcare infrastructure and stronger pharmaceutical R&D. Against this backdrop, we are proud to be joined by Infors, showcasing bioreactor equipment designed to support research, process development and sustainable biotech production.
The Multitron incubator shaker is engineered for large-scale parallel incubation. With a compact footprint, its triple-stacked system can cultivate 63 L or 23,000 experiments simultaneously in under a square metre. This scale is particularly relevant in regions like the UAE and Saudi Arabia, where increased government support for biotechnology and pharma R&D is accelerating demand for incubator shakers and orbital shakers that ensure efficiency in limited laboratory space.
Multitron Key Highlights:
The system’s sustainability credentials mirror wider regional initiatives investing in greener, more responsible lab infrastructure.
The Minifors 2 bioreactor package is an entry-level table top incubator system that simplifies microbial and mammalian cell culture. Delivered preconfigured, it enables rapid setup and reliable use, aligning with the growth of small research labs across the Middle East’s expanding healthcare and life sciences sectors.
Minifors 2 Features:
As the global bioreactor market is projected to reach USD 46.61 billion by 2033 at 11.4% CAGR, systems like Minifors 2 reflect how laboratories are increasingly seeking compact yet advanced fermentation bioreactor solutions.
For labs ready to scale further, the Labfors 5 stirred tank bioreactor supports a wide range of volumes and process configurations. It offers control over batch, fed-batch and continuous cultivation, with optional high-torque motors reaching speeds up to 1500 rpm.
Labfors 5 Advantages:
With the Middle East strengthening its position in biopharmaceutical production, especially in Saudi Arabia and the UAE, stirred tank bioreactors like Labfors 5 align directly with regional strategies to expand vaccine, biologics and antibody research capacity. Globally, even single-use bioreactors are projected to grow from USD 4.2 billion in 2024 to over USD 16 billion by 2032 at 18.37% CAGR, underlining the momentum in bioprocess innovation.
Product | Capacity / Volumes | Distinct Features | Primary Application |
---|---|---|---|
Multitron Incubator Shaker | 63 L or 23,000 experiments | Triple stack, ACT label, ISO 4 HEPA filtration | Large-scale parallel incubation |
Minifors 2 Bioreactor | 1.5–6 L vessels (0.3–4 L working) | Plug-and-play setup, eve® software | Lab-scale fermentation & culture |
Labfors 5 Bioreactor | 2–13 L vessels (0.5–10 L working) | Touchscreen parallel control, high-torque motors | Advanced process development |
The ArabLab 2025 exhibition will highlight how global and regional markets are converging. With the Middle East laboratory equipment sector projected to almost double by 2033, demand for advanced laboratory bioreactors, fermentors and bioreactor fermentors is rapidly rising.
We at BCL are bringing our curated range of innovations to this platform, joined by Infors to showcase how Multitron, Minifors 2 and Labfors 5 bioreactors are answering both local and global needs for scalable, sustainable bioprocessing.
Can you afford to miss this chance? Create a reminder on your calendar with the event details today! We will be eagerly awaiting your presence.
Dubai World Trade Centre
23–25 September 2025
Stall No: H2–C70